Stockreport

GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy [Yahoo! Finance]

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation
PDF pioneering development of next generation cannabinoid therapeutics and consumer products today announced that it has completed the preclinical phase of assessing its nov [Read more]